Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: A case report

Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.